SCHEMBL2274466

SCHEMBL2274466

CC(=O)C(C(=O)CF)(C(=O)CF)C(=O)CF

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929402 0.97 CASP1 (0.30) CASP1
SCHEMBL7564418 0.74 FAAH (0.31) CASP1
SCHEMBL8160285 0.72 GAA (0.31)
SCHEMBL27910860 0.72 FAAH (0.30)
SCHEMBL5664803 0.72
SCHEMBL27922262 0.72 FAAH (0.30)
SCHEMBL28243362 0.72 FAAH (0.30)
SCHEMBL8752311 0.71 TSHR (0.35)
SCHEMBL8153782 0.70
SCHEMBL4881380 0.69 LMNA (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028685-A1 Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids UNIV COLORADO REGENTS (US) 2026-01-29 US claimed
WO-2021236696-A1 SALIVA STABILIZATION SOLUTION FOR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS AND METHODS OF USE FOR THE DETECTION OF PATHOGEN NUCLEIC ACIDS THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE (US) 2021-11-25 WO claimed
CN-111825643-A Preparation method of 2, 5-dicyanofuran 中国科学院大连化学物理研究所 2020-10-27 CN claimed
US-10329480-B2 Sheet integrated rare earth complex and use thereof NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2019-06-25 US claimed
CN-109678722-A A kind of linear carbonate and its synthetic method containing fluoroalkyl 常熟市常吉化工有限公司 2019-04-26 CN claimed
CN-108899513-A A kind of preparation method of the trielement composite material containing organic salt 江苏乐能电池股份有限公司 2018-11-27 CN claimed
US-20180334472-A1 POLYMER COMPLEX AND PRODUCTION PROCESS THEREFOR NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2018-11-22 US claimed
CN-107382688-A Efficiently synthesize the method and its application of tri acetylacetonato ruthenium 郴州高鑫铂业有限公司 2017-11-24 CN claimed
CN-107159258-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-09-15 CN claimed
CN-107159255-A The preparation method of ozone Heterogeneous oxidation solid catalyst 四川师范大学 2017-09-15 CN claimed
CN-1425642-A Method of catalyzing esterification of carboxylic acid and expoxy compound GUANGZHOU INST OF CHEMISTRY (CN) 2003-06-25 CN claimed
US-20030099424-A1 Optical gain media and methods for making and using same MOHAJER YOUSEF (US) 2003-05-29 US claimed
EP-0405634-B1 Volatile organic barium, strontium and calcium compounds and method for the preparation of layered materials with barium, strontium or calcium oxides or fluorides from these compounds ASS OCTEL (GB) 2000-08-30 EP claimed
EP-0546669-B1 Preparation of fluorine-doped tungstic oxide and glass coating process FORD MOTOR CO (GB) 1996-04-17 EP claimed
US-5385751-A Atmospheric pressure CVD process for preparing fluorine-doped tungsten oxide films FORD MOTOR COMPANY (US) 1995-01-31 US claimed
US-5286520-A Reacting tungsten hexafluoride, an oxygen containing compound and a fluorine containing compound FORD MOTOR COMPANY (US) 1994-02-15 US claimed
EP-0546669-A1 Preparation of fluorine-doped tungstic oxide and glass coating process FORD MOTOR COMPANY LIMITED (GB) 1993-06-16 EP claimed
US-4696837-A Chemical vapor deposition method of producing fluorine-doped tin oxide coatings M&T CHEMICALS INC. (US) 1987-09-29 US claimed
US-4601917-A CHEMICAL VAPOR DEPOSITION M&T CHEMICALS INC. (US) 1986-07-22 US claimed
US-4031103-A BRONCHODILATOR AGENTS, 2,6-DIAMINOPYRIDINE, DIKETONE COMPOUND MERCK SHARP & DOHME (I.A.) CORPORATION (US) 1977-06-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028685-A1 Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids RNASEH1, ACE2, DDX42 CASP1 2083/4885
US-10329480-B2 Sheet integrated rare earth complex and use thereof EMC1, TERB1, TPR CASP1 3682/4885
US-20180334472-A1 POLYMER COMPLEX AND PRODUCTION PROCESS THEREFOR SLC39A11, RPS11, OR10J3 CASP1 4502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.